Development of Diagnostics for Chagas Disease: Where Should We Put Our Limited Resources?
PLoS Negl Trop Dis
.
2017 Jan 5;11(1):e0005148.
doi: 10.1371/journal.pntd.0005148.
eCollection 2017 Jan.
Authors
Albert Picado
1
,
Andrea Angheben
2
,
Andrea Marchiol
3
,
Belkisyolé Alarcón de Noya
4
,
Laurence Flevaud
5
,
Maria Jesus Pinazo
6
,
Montserrat Gállego
6
7
,
Sheba Meymandi
8
,
Silvia Moriana
9
Affiliations
1
Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
2
Centre for Tropical Diseases, Hospital Sacro Cuore, Don Calabria, Negrar, Verona, Italy.
3
Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
4
Immunology Section, Instituto de Medicina Tropical, Facultad de Medicina, Universidad Central de Venezuela, Caracas, Venezuela.
5
Médecins Sans Frontières Operational Centre Barcelona-Athens (MSF OCBA), Barcelona, Spain.
6
ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
7
Secció de Parasitologia, Departament de Biologia, Sanitat i Medi Ambient, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Spain.
8
Department of Cardiology, Center of Excellence for Chagas Disease at Olive View-UCLA Medical Center, Sylmar, California, United States of America.
9
The Global Chagas Disease Coalition, Barcelona, Spain.
PMID:
28056025
PMCID:
PMC5221646
DOI:
10.1371/journal.pntd.0005148
No abstract available
MeSH terms
Chagas Disease / diagnosis*
Chagas Disease / economics
Diagnostic Tests, Routine / economics*
Humans
Grants and funding
The authors received no specific funding for this work.